A genetic progression model of oral cancer: current evidence and clinical implications
- 16 June 2004
- journal article
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 33 (6) , 317-322
- https://doi.org/10.1111/j.1600-0714.2004.00225.x
Abstract
Based on recent genetic studies, we propose a progression model for the development of oral squamous cell carcinoma. In the initial phase, a stem cell acquires a genetic alteration; subsequently a patch is formed, a clonal unit consisting of the stem cell with its daughter cells that all share the DNA alteration. The next critical step is the conversion of a patch into an expanding field as a result of additional genetic alterations. This mucosal field replaces the normal epithelium and in the oral cavity such fields have been detected with dimensions of over 7 cm in diameter. Sometimes these fields are visible as leukoplakia. Ultimately, clonal selection leads to the development of carcinoma within this contiguous field of pre-neoplastic cells. An important clinical implication of this model is that fields often remain after surgery of the primary tumor and may lead to new cancers, presently designated by clinicians as second primary tumors or local recurrences.Keywords
This publication has 32 references indexed in Scilit:
- Stem cells and breast cancer: A field in transitNature Reviews Cancer, 2003
- Multistage carcinogenesis and the incidence of human cancerGenes, Chromosomes and Cancer, 2003
- Genomic instability — the engine of tumorigenesis?Nature Reviews Cancer, 2003
- The significance of unstable chromosomes in colorectal cancerNature Reviews Cancer, 2003
- Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynxThe Journal of Pathology, 2003
- DNA Content as a Prognostic Marker in Patients with Oral LeukoplakiaNew England Journal of Medicine, 2001
- The Hallmarks of CancerCell, 2000
- Concomitant leukoplakia in patients with oral squamous cell carcinomaOral Diseases, 1999
- Field cancerisation and polyclonal p53 mutation in the upper aero- digestive tractOncogene, 1997
- Is the carbohydrate sialosyl-Tn a marker for altered, non-malignant activity in squamous epithelium in the head and neck region?The Journal of Pathology, 1995